. 2015 Aug 25;6(10):1168–1178. doi: 10.4239/wjd.v6.i10.1168

Table 1.

Blood glucose (mg/dL) in diabetic and control rats treated with statins

Condition	Day 0	Day 1	Day 7	Day 14	Day 28
CT none	131.25 ± 3.14	130.50 ± 1.51	126.78 ± 4.86	112.42 ± 4.55	133.88 ± 13.66
CT + AV	137.0 ± 5.86	123.33 ± 2.85	126.8 ± 2.2	128.40 ± 7.02	180.67 ± 52.21
CT + SV	143.13 ± 1.75	128.50 ± 3.10	126.80 ± 2.22	128.40 ± 7.02	152.88 ± 18.46
CT + PV	142.63 ± 5.79	127.13 ± 3.36	122.20 ± 4.79	120.80 ± 4.47	130.63 ± 4.06
Diabetic none	133.65 ± 3.51	445.41 ± 24.11^a	490.45 ± 34.34^a	530.09 ± 26.65^a	517.76 ± 18.11^a
Diabetic + AV	133.00 ± 3.30	473.82 ± 40.23^a	497.38 ± 47.68^a	485.38 ± 48.73^a	500.73 ± 32.65^a
Diabetic + SV	133.75 ± 2.70	413.19 ± 21.22^a	473.69 ± 27.39^a	483.23 ± 39.90^a	498.94 ± 30.62^a
Diabetic + PV	126.88 ± 2.08	430.44 ± 27.31^a	524.38 ± 19.92^a	564.85 ± 13.57^a	557.25 ± 12.92^a

P < 0.05 vs age-matched C. Values are means ± SEM. Rats were injected with STZ on day 0. Blood glucose for diabetic rats: n = average of 10 rats per group. AV: Atorvastatin; SV: Simvastatin; PV: Pravastatin; CT: Control; STZ: Streptozotocin.